tiprankstipranks
Terns Pharmaceuticals (TERN)
NASDAQ:TERN

Terns Pharmaceuticals (TERN) Balance Sheet

161 Followers

Terns Pharmaceuticals Balance Sheet

Terns Pharmaceuticals's total assets for Q1 2024 were $246.77M, a decrease of -9.17% from the previous quarter. TERN total liabilities were $10.05M for the fiscal quarter, a -24.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 268.52M$ 287.03M$ 168.07M$ 92.29M$ 23.90M
Total Liabilities
$ 13.15M$ 10.08M$ 7.77M$ 23.70M$ 19.70M
Total Equity Gross Minority
$ 255.37M$ 276.94M$ 160.30M$ 68.59M$ 4.21M
Total Capitalization
$ 255.37M$ 278.03M$ 160.30M$ 68.59M$ 4.21M
Preferred Stock Equity
---$ 186.03M$ 94.97M
Capital Lease Obligations
-----
Currency in USD

Terns Pharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis